Anti-vascular endothelial growth factor therapy for ocular diseases of neovascularizatio
Not Applicable
- Conditions
- retinopathy of prematurity neovascular glaucome vasoproliferative tumor choroidal neovascularization
- Registration Number
- JPRN-UMIN000027243
- Lead Sponsor
- School of Medicine Toho University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1, high risk of stroke infarction 2, high risk of myocardial infarction 3, ocular infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of ocular blood flow at 1 week, 1 months and 3 months from the initial treatment.
- Secondary Outcome Measures
Name Time Method